Ocular migraine: when one eye goes dark and the brain is the one to ask.

Losing vision in one eye is terrifying and must always be checked. Once the dangerous causes are excluded, the condition that remains is a brain event, not an eye one.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

First, get the eye and the blood vessels checked

Ocular migraine is the everyday name for what the headache classification calls retinal migraine: repeated, fully reversible episodes of visual disturbance in one eye, such as flashes, a blind spot or complete loss of vision, accompanied or followed within an hour by a migraine headache. You may also hear it called visual, ophthalmic or monocular migraine. The key word is monocular, one eye. Ordinary migraine aura affects the same part of the visual field in both eyes, because it originates in the brain's visual cortex, and people often mistake it for a one-eye problem.

This is a diagnosis of exclusion, and the exclusions matter. Sudden loss of vision in one eye can be caused by a clot or spasm in the retinal artery, a tear in the carotid artery, inflammation of the arteries, a retinal detachment, or raised pressure in the eye. Several of these threaten the eye or the brain and are treatable only if caught quickly. So the first episode of monocular vision loss should be seen urgently by an ophthalmologist or emergency department, with imaging of the blood vessels where indicated.

Once those causes are excluded and the pattern is recurrent and fully reversible, retinal migraine becomes the working diagnosis. Even then, as the research below shows, many such cases are better described as retinal vasospasm, a temporary narrowing of the eye's blood vessels, than as migraine proper.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms produced by learned pathways in the brain and nervous system rather than by ongoing damage in the body. Migraine itself is a condition of a hypersensitive brain: a nervous system that reacts to light, sound, hormones, sleep loss and stress with a cascade that produces pain and, in aura, temporary changes in vision. The eye is not damaged during a retinal migraine; the vessels or nerves serving it are briefly behaving as the nervous system instructs. The symptoms are genuine. They are not imaginary and not 'all in your head'. And because they come from a sensitized system, the sensitivity can be reduced.

The ATNS Index of Neuroplastic Symptoms says that for ocular migraine, neuroplastic symptoms should be assessed as part of a complete evaluation. It does not say the eye examination can be skipped, and it does not say every attack is neuroplastic. It says that after the structural evaluation, the nervous system's role deserves assessment, which fits what is known about migraine in general: attack frequency and severity are tightly linked to stress, fear of the next attack, sleep and mood.

Patterns that point toward a significant neuroplastic contribution:

• Attacks cluster around stressful periods, or in the let-down after them.
• The fear of losing vision has become constant, with checking and scanning of your eyesight between attacks.
• Episodes have become more frequent despite normal eye and vascular findings.
• Other migraine forms, headaches or unexplained symptoms accompany them.

Our guide to central sensitization explains the hypersensitivity at the root of migraine. See also migraine, vestibular migraine and blurred vision.

What the research shows

We should be direct: there is no research on neuroplastic symptoms in retinal migraine specifically, and the condition is rare enough that most of the literature consists of case reports and reviews. What the literature does establish is how carefully the diagnosis should be made, and how often it is applied loosely.

A 2007 analysis in the Journal of Neuro-Ophthalmology, titled 'Most cases labeled as retinal migraine are not migraine', reviewed published cases and found that of 16 patients with transient monocular vision loss whose features were consistent with retinal migraine, only five met the formal criteria, and none of those with permanent visual loss did. The authors suggested most such episodes are better called presumed retinal vasospasm. A 2021 review, 'Current Perspective on Retinal Migraine', reaffirms that it is a diagnosis of exclusion requiring that carotid dissection and other vascular causes be ruled out, and that careful history-taking is the cornerstone.

A 2025 systematic review of 65 studies compared retinal migraine with migraine with aura. It characterised retinal migraine as monocular in about 90 percent of cases, dominated by negative symptoms such as a blind spot or vision loss, usually lasting under an hour, with a vascular mechanism and rare permanent loss, whereas migraine with aura is typically binocular and cortical. For the nervous-system contribution, the honest statement is that this is inferred from the wider migraine literature, where stress, sensitization and fear of attacks are well-established drivers, rather than demonstrated in this rare subtype.

Signs the brain may be part of the picture

• Ophthalmology and vascular evaluation are normal and the episodes are fully reversible.
• Attacks follow stress, sleep loss, or the relief after a stressful period.
• Between attacks you check your vision constantly and feel dread about the next one.
• You also have other migraine types, tension headaches, or unexplained symptoms.

A solution that addresses it

Pain and symptom reprocessing is an approach built to lower the nervous system's sensitivity. For migraine it means education about neuroplastic symptoms, somatic tracking (observing the early signs of an attack with curiosity rather than panic), reducing fear and the sense of threat, graded return to the activities and light levels you have been avoiding, emotional awareness and expression, and acceptance and commitment skills. Trained clinicians deliver it, and digital programs now make it more accessible. It works alongside migraine medication and ophthalmology follow-up, never in place of them.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If you have ocular migraine and the fear of the next attack has taken over, you can join the waitlist.

What to do next

1. Treat any first or unusual episode as urgent. Sudden vision loss in one eye, especially with weakness, speech difficulty, facial droop, neck pain, jaw pain or scalp tenderness, needs emergency assessment. Do not wait for it to pass.
2. Get the full eye and vascular workup. Ophthalmology examination and, where indicated, imaging of the carotid arteries and blood tests for arterial inflammation.
3. Once cleared, manage the migraine. Follow your neurologist's plan, and keep a simple diary of attacks against sleep, stress and triggers.
4. Ask the question. 'Could my nervous system's sensitivity be driving the frequency?' The ATNS index says to assess for neuroplastic symptoms as part of the complete evaluation. Then begin the practice below and look at our flare plan for handling attacks without panic.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.